Navigation Links
GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
Date:6/3/2009

TBWA assigned alli and Smoking Control

Grey assigned US brands TUMS, Citrucel and FiberChoice

PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline Consumer Healthcare (GSK Consumer Healthcare) (NYSE: GSK) has announced advertising agency changes to support growth for global brands. The changes will see GSK Consumer Healthcare partnering with agencies that have comparable market presence to its brands, with a proven ability to roll out world class ideas.

TBWA, part of the Omnicom Group, is appointed GSK's global creative agency for the weight loss brand alli(R) and for the Smoking Control franchise, including Nicorette(R), NicoDerm(R) CQ and Commit(R) sold in the US. TBWA won these global assignments following a rigorous appointment process facilitated by Agency Assessments International. The global creative agency accounts were previously held by Arnold, New York.

Grey currently manages the accounts for a number of GSK's global brands -- Aquafresh(R), Sensodyne(R), Denture Care (Polident(R), Poligrip(R) and Corega(R)) and Breathe Right(R). They have also been awarded TUMS(R), Citrucel(R) and FiberChoice(R) in the US. The agency account for TUMS and Citrucel was previously held by Arnold, New York. The agency account for FiberChoice was previously held by Nelson Henry.

Commenting on the agency assignments, Peter Kirkby, Vice President, Global Marketing Excellence, GSK Consumer Healthcare, said: "GSK Consumer Healthcare has an industry-leading, balanced brand presence in both the world's developed and fastest-growing markets. Our global brands are fundamental to future growth strategy and we want to partner with world class communications agencies with a solid global footprint that can help us drive growth.

"We were enormously impressed by TBWA's passion and performance throughout the pitch process. TBWA won their assignments based on the strength of their strategic thinking and their ability to drive big, brand-driven, creative ideas across the world's most dynamic and fast-growing markets.

"Our association with Grey is reaching new heights. Recent work on Aquafresh, Sensodyne, Denture Care and Breathe Right has been enormously successful. I am very pleased to see these additional brands assigned to their highly capable teams."

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as well as many medicine cabinet staples, including Abreva(R), Aquafresh(R), Sensodyne(R), TUMS(R) and Breathe Right(R).

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.


'/>"/>
SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris ... of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking ... in the field of medical informatics, this prestigious award is presented to an individual ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
Breaking Medicine Technology: